Advertisement

Ads Placeholder
Loading...

Basilea Pharmaceutica AG

BPMUFPNK
Healthcare
Biotechnology
$71.00
$0.00(0.00%)
U.S. Market opens in 6h 41m

Basilea Pharmaceutica AG (BPMUF) Stock Competitors & Peer Comparison

See (BPMUF) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BPMUF$71.00+0.00%871.4M9.97$7.12N/A
NONOF$37.12+5.97%159.3B10.07$3.56+3.97%
CSLLY$24.98-0.60%96.9B16.25$1.54+2.92%
UCBJY$159.36+2.13%60.7B34.27$4.65+0.50%
UCBJF$318.65-2.37%60.7B34.34$9.28+0.50%
CMXHF$98.24+11.26%47.7B15.92$6.17+2.96%
ARGNF$712.03+0.00%44.1B36.36$19.58N/A
IVBXF$11.15-2.19%19.2B159.21$0.07N/A
WXIBF$4.60+0.00%19B27.06$0.17N/A
WXXWY$9.10+2.36%18.7B26.59$0.34N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BPMUF vs NONOF Comparison April 2026

BPMUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BPMUF stands at 871.4M. In comparison, NONOF has a market cap of 159.3B. Regarding current trading prices, BPMUF is priced at $71.00, while NONOF trades at $37.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BPMUF currently has a P/E ratio of 9.97, whereas NONOF's P/E ratio is 10.07. In terms of profitability, BPMUF's ROE is +0.35%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, BPMUF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for BPMUF.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions